| 1360 |
National Cancer Institute |
Html |
en |
Depression (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the diagnosis, assessment, and treatment of depression in adults and children who have cancer. |
| suicide risk | 0.460973 |
| atypical depression | 0.41847 |
| subsyndromal depression | 0.457817 |
| depressive symptoms | 0.584368 |
| suicidal cancer patients | 0.447773 |
| depression symptomatology. | 0.419123 |
| subclinical depression | 0.442864 |
| adult cancer patients | 0.517419 |
| major depression | 0.691882 |
| adolescent cancer patients | 0.429802 |
| risk factors | 0.484688 |
| sexual dysfunction | 0.434954 |
| patients | 0.713623 |
| cancer patients | 0.698109 |
| suicidal ideation | 0.513185 |
| cancer diagnosis | 0.413017 |
| major depressive episode | 0.43272 |
| reactive depression | 0.424412 |
| anxiety | 0.444105 |
| effects | 0.535659 |
| refractory depression | 0.443531 |
| certain cancer types | 0.406666 |
| minor depression | 0.440711 |
| hot flashes | 0.408417 |
| noradrenergic effects | 0.403735 |
|
| Cancer Patients section | 0.442778 |
| treatment | 0.464007 |
| study | 0.404546 |
| clinical depression | 0.428638 |
| general population | 0.440244 |
| palliative care | 0.4121 |
| significant depression symptomatology | 0.449959 |
| Depression Scale–defined depression | 0.582176 |
| higher suicide risk | 0.426624 |
| adjustment disorder | 0.407394 |
| definitive cancer treatment | 0.418565 |
| cancer patients. | 0.417656 |
| Depression Rating Scale. | 0.455048 |
| breast cancer | 0.43696 |
| ill cancer patients | 0.449049 |
| visual analog scale | 0.432777 |
| depressed cancer patients | 0.434755 |
| cancer-related depression | 0.43502 |
| neck cancer | 0.415737 |
| physical symptoms | 0.402781 |
| Mental Disorders | 0.404693 |
| cancer | 0.740348 |
| risk | 0.54097 |
| depression | 0.900167 |
|
CLICK HERE |
| 1407 |
National Cancer Institute |
Html |
en |
Adult Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version |
Expert-reviewed information summary about the treatment of adult soft tissue sarcoma. |
| soft tissue sarcomas | 0.852178 |
| adjuvant chemotherapy | 0.346182 |
| metastatic soft tissue | 0.248446 |
| extremity sarcomas | 0.215308 |
| treatment | 0.205088 |
| bone sarcoma group | 0.220998 |
| soft tissue | 0.907283 |
| resectable soft tissue | 0.235708 |
| soft-tissue sarcoma | 0.237332 |
| Abstract | 0.206867 |
|
| patients | 0.337908 |
| Clin Oncol | 0.267307 |
| extremity soft tissue | 0.314357 |
| adult soft tissue | 0.260712 |
| trial | 0.209038 |
| radiation therapy | 0.357434 |
| local recurrence | 0.25142 |
| soft tissue sarcoma | 0.709488 |
| high-grade soft tissue | 0.212019 |
| Cancer Soft Tissue | 0.205799 |
|
CLICK HERE |
| 1752 |
National Cancer Institute |
Html |
en |
Common Moles, Dysplastic Nevi, and Risk of Melanoma |
A fact sheet about moles and how some moles may be related to melanoma, the most serious type of skin cancer. Includes photos of differences between moles and cancer. |
| skin cancer | 0.396204 |
| new pencil eraser | 0.340631 |
| new mole | 0.324515 |
| people—have common moles | 0.296925 |
| areas | 0.255107 |
| Cancer Statistics Review | 0.258106 |
| skin surface | 0.252994 |
| American Cancer Society | 0.291862 |
| dysplastic nevi | 0.760688 |
| ABCDE features | 0.255948 |
| shape | 0.300226 |
| normal moles | 0.26535 |
| melanoma | 0.905882 |
| new moles | 0.27436 |
| distinct edge | 0.298497 |
| UV radiation | 0.254044 |
| mole look | 0.348624 |
| early melanoma | 0.368768 |
| color changes | 0.261127 |
| following changes | 0.256625 |
| moderately increased chance | 0.26864 |
| dysplastic nevus | 0.99874 |
| dark skin | 0.328273 |
| skin damage | 0.265216 |
|
| new colored area | 0.350978 |
| mole changes | 0.343324 |
| skin | 0.706105 |
| people—develop melanoma | 0.334635 |
| cancer cells | 0.262185 |
| sun | 0.303017 |
| atypical mole | 0.288433 |
| National Cancer Institute | 0.258053 |
| frequent skin exam | 0.273598 |
| common moles | 0.677867 |
| chance | 0.337967 |
| greater chance | 0.265511 |
| American adults—about | 0.256684 |
| surface texture | 0.317122 |
| Evolving. The mole | 0.285916 |
| people | 0.632361 |
| doctor | 0.289469 |
| normal skin tone | 0.268972 |
| family history | 0.256672 |
| early melanoma detection | 0.355222 |
| unusual mole | 0.314622 |
| common mole | 0.732427 |
| common mole look | 0.339723 |
| fair skin | 0.271925 |
|
CLICK HERE |
| 1789 |
National Cancer Institute |
Html |
es |
Complicaciones gastrointestinales (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del estreñimiento, impacción, obstrucción intestinal y diarrea como complicaciones del cáncer o su tratamiento. Se discute el manejo de estos problemas. |
| PDQ Complicaciones | 0.530388 |
| pelvis causa inflamación | 0.572317 |
| siguientes procedimientos | 0.608568 |
| hormona tiroidea | 0.545669 |
| siguientes aspectos | 0.533891 |
| Lactobacillus acidophilus | 0.526037 |
| rayos x | 0.532507 |
| media hora | 0.541392 |
| diarrea aguda | 0.693188 |
| largo plazo | 0.569789 |
| siguientes preguntas | 0.540731 |
| Busque privacidad | 0.543195 |
| productos lácteos | 0.560479 |
| medicamentos iv | 0.544267 |
| siguientes indicaciones | 0.527177 |
| tratamiento quizás | 0.572007 |
| vÃa iv | 0.522455 |
| cáncer.ampliar colonoscopia | 0.551466 |
| Instituto Nacional | 0.536707 |
| Coma porciones | 0.524947 |
| heces retenidas | 0.545367 |
| intestino.ampliar procedimiento | 0.541183 |
| suficiente ejercicio | 0.545879 |
| crónica.Obstrucción intestinal aguda | 0.64888 |
|
| pacientes quizás | 0.581825 |
| sÃntomas quizás | 0.540102 |
| metabolismo corporal concentración | 0.581977 |
| cantidades correctas | 0.533739 |
| régimen brat | 0.52571 |
| ¿El estreñimiento | 0.640368 |
| medicamentos opioides | 0.717569 |
| ejercicio lesión | 0.545303 |
| gráfico muestra afecciones | 0.567465 |
| National Cancer Institute | 0.520678 |
| La nutrición | 0.589361 |
| alto contenido | 0.5222 |
| siguientes signos | 0.535436 |
| Physician Data Query | 0.576854 |
| enzimas pancreáticas | 0.556797 |
| radiación aguda | 0.557929 |
| cuerpo).ampliar anatomÃa | 0.552347 |
| RadiografÃa abdominal | 0.535361 |
| suficiente cantidad | 0.531328 |
| enteritis aguda | 0.993176 |
| siguientes complicaciones | 0.586671 |
| obstrucción intestinal aguda | 0.803119 |
| cirugÃa.Algunos medicamentos | 0.559484 |
| siguientes pruebas | 0.618199 |
|
CLICK HERE |
| 1792 |
National Cancer Institute |
Html |
es |
Náuseas y vómitos relacionados con el tratamiento del cáncer (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca de las náuseas y vómitos como complicaciones del cáncer o su tratamiento. Se plantean abordajes de tratamiento de las náuseas y vómitos. |
| radioterapia nombre | 0.366149 |
| Dexametasona Corticosteroides | 0.345517 |
| palonosetrón antagonistas | 0.420992 |
| siguientes tipos | 0.357417 |
| siguientes estrategias | 0.348254 |
| único signo | 0.33198 |
| causa náuseas | 0.753796 |
| National Cancer Institute | 0.339057 |
| determinados medicamentos | 0.5578 |
| siguientes riesgos | 0.330997 |
| quimioterapia nombre | 0.555099 |
| PDQ Acupuntura | 0.392476 |
| Instituto Nacional | 0.371538 |
|
| siguientes problemas | 0.372583 |
| siguientes factores | 0.44966 |
| Physician Data Query | 0.449355 |
| Lorazepam Benzodiazepinas | 0.337793 |
| vómitos tardÃos | 0.949937 |
| siguientes caracterÃsticas | 0.461706 |
| determinadas situaciones | 0.34995 |
| fosaprepitant antagonistas | 0.342662 |
| prometazina fenotiacinas | 0.421253 |
| PDQ Náuseas | 0.567745 |
| medicamento tipo | 0.522815 |
| flujo sanguÃneo escaso | 0.412994 |
| haloperidol butirofenonas | 0.346571 |
|
CLICK HERE |
| 1795 |
National Cancer Institute |
Html |
es |
Delirium (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del delirium como una complicación del cáncer o su tratamiento. Se describen enfoques de los cuidados médicos de apoyo y los abordajes farmacológicos para el manejo del delirium. |
| suficiente agua | 0.391829 |
| siguientes ajustes | 0.389418 |
| siguientes procedimientos | 0.397737 |
| cuánto medicamento | 0.399542 |
| problemas renales | 0.399254 |
| siguientes aspectos | 0.450474 |
| examen fÃsico ayuda | 0.42207 |
| Physician Data Query | 0.564236 |
| sistema nervioso central | 0.485961 |
|
| PDQ Delirium | 0.632187 |
| múltiples alteraciones | 0.425648 |
| término delirium | 0.901451 |
| delirium ayuda | 0.774253 |
| equipo médico tomarán | 0.402369 |
| siguientes sÃntomas | 0.497019 |
| National Cancer Institute | 0.363151 |
| siguientes riesgos | 0.350297 |
| Instituto Nacional | 0.421085 |
|
CLICK HERE |
| 1823 |
National Cancer Institute |
Html |
es |
Tratamiento del sarcoma de tejido blando en adultos (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento del sarcoma de tejido blando en adultos. |
| Scandinavian Sarcoma Group | 0.539831 |
| Lippincott Williams | 0.562481 |
| bEl tumor | 0.509518 |
| Compton CC | 0.522215 |
| Cancer Institute Surveillance | 0.506324 |
| Antonescu CR | 0.5084 |
| Sarcoma Group | 0.551693 |
| Sin embargo | 0.587887 |
| tumor center | 0.509169 |
| observación versus | 0.507069 |
| largo plazo | 0.5106 |
| 7th ed | 0.522519 |
| DeVita VT Jr | 0.615914 |
| from sarcomas | 0.514899 |
| Tumores osteocondrales.Condrosarcomas | 0.512024 |
| Prognostic factors | 0.507702 |
| lymph nodes | 0.507203 |
| Rosenberg SA | 0.558836 |
| T1b Tumor | 0.509623 |
| tumor lipomatoso atÃpico | 0.511636 |
| soft tissue sarcoma | 0.94016 |
| Lawrence TS | 0.559677 |
| fibroso maligno | 0.507755 |
| Cancer Centers Sarcoma | 0.522459 |
| localised limb soft | 0.508432 |
|
| sarcoma patients | 0.519354 |
| metastasis from soft | 0.508028 |
| Tumores vasculares.Hemangioendotelioma | 0.512057 |
| O'Sullivan B | 0.529169 |
| tratamiento adyuvante versus | 0.512692 |
| versus quimioterapia | 0.510953 |
| Malawer MM | 0.508085 |
| Nielsen T | 0.507472 |
| Tumores adipocÃticos.Liposarcoma | 0.51216 |
| Cancer Staging Manual | 0.545483 |
| Maki RG | 0.50832 |
| potencial metastásico | 0.508732 |
| recidivas locales | 0.527298 |
| New York | 0.519322 |
| 9th ed | 0.564335 |
| high risk soft | 0.507723 |
| adult soft tissue | 0.530167 |
| Byrd DR | 0.520996 |
| T2b Tumor | 0.50961 |
| mutación genética ptc | 0.506056 |
| Helman LJ | 0.508415 |
| Sarcoma Group study | 0.521636 |
| Molecular biology | 0.507762 |
| AJCC Cancer Staging | 0.547586 |
|
CLICK HERE |
| 1850 |
National Cancer Institute |
Html |
es |
Tratamiento del timoma y carcinoma tímico (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento del timoma y carcinoma tímico. |
| invasive thymic carcinoma | 0.2596 |
| timoma tipo | 0.753284 |
| Loehrer PJ | 0.311974 |
| staging does not | 0.262543 |
| current staging does | 0.263941 |
| thymic epithelial neoplasms | 0.240861 |
| clinicopathologic study | 0.267111 |
| thymic epithelial tumors | 0.352929 |
| does not predict | 0.26201 |
| largo plazo | 0.279368 |
| estadio iva | 0.280139 |
| classification system reflects | 0.276691 |
| Carcinoma tÃmico mucoepidermoideEste | 0.258374 |
| Thorac Oncol | 0.241866 |
| clinical study | 0.318669 |
| tipo b2 | 0.255669 |
| Radiat Oncol Biol | 0.298534 |
| World Health Organization | 0.376953 |
| Thomas CR | 0.251437 |
| Loehrer PJ Sr | 0.250531 |
| linfocitos t | 0.238031 |
| patients with | 0.335568 |
| Organization histologic classification | 0.322145 |
| tÃmico papilarEste tipo | 0.238335 |
| timoma tipo b1 | 0.326133 |
|
| thymoma cases from | 0.25857 |
| with completely resected | 0.252233 |
| caracterÃsticas citológicas | 0.238638 |
| thymic carcinoma | 0.907691 |
| histologic classification system | 0.279611 |
| classification predicts prognosis | 0.243585 |
| myasthenia gravis | 0.300079 |
| WHO histologic classification | 0.270221 |
| unresectable malignant thymomas | 0.248319 |
| tipo ab | 0.279847 |
| not predict prognosis | 0.263382 |
| is correlated with | 0.24461 |
| patients with completely | 0.257759 |
| Thorac Cardiovasc Surg | 0.595787 |
| thymoma with | 0.272559 |
| carcinoma basaloide | 0.243654 |
| Clin Oncol | 0.356331 |
| Oncol Biol Phys | 0.300373 |
| estadio iii | 0.482375 |
| Health Organization histologic | 0.299614 |
| histologic classification | 0.363646 |
| Thorac Surg | 0.582943 |
| malignant thymoma | 0.481068 |
| Toita T | 0.262072 |
|
CLICK HERE |
| 2026 |
National Cancer Institute |
Html |
es |
Prevención del cáncer colorrectal (PDQ®)–Versión para profesionales de salud |
Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer colorrectal y sobre las investigaciones dirigidas a la prevención de esta enfermedad. |
| colorectal adenoma chemoprevention | 0.338068 |
| colorectal neoplasia among | 0.319011 |
| long-term risk | 0.313313 |
| Adults With Colorectal | 0.319346 |
| Sin embargo | 0.339382 |
| Gastrointest Endosc | 0.311269 |
| largo plazo | 0.32477 |
| CPS II | 0.314437 |
| flexible sigmoidoscopy screening | 0.31731 |
| Preventive Services Task | 0.332229 |
| colorectal cancer | 0.908646 |
| population-based study | 0.314294 |
| Estados Unidos | 0.331084 |
| Natl Cancer Inst | 0.334301 |
| Women's Health Study | 0.324602 |
| after colonoscopy | 0.309105 |
| CCR multivariantes | 0.345859 |
| Aspirin Trial | 0.311104 |
| Women's Health Initiative | 0.338408 |
| colorectal adenomatous polyps | 0.317676 |
| Health Initiative | 0.348288 |
| colorrectal hereditario | 0.317986 |
| Women's Health | 0.346194 |
| cancer prevention | 0.326424 |
| Rothwell PM | 0.314674 |
|
| colorectal adenoma | 0.357654 |
| Health Study | 0.364941 |
| sporadic colorectal adenomas | 0.324242 |
| RR multivariante | 0.309686 |
| CCR clÃnico | 0.37477 |
| Health Study Research | 0.310687 |
| left-sided colorectal neoplasms | 0.31858 |
| primary prevention | 0.311318 |
| Hereditary Cancer Syndromes | 0.314398 |
| Epidemiol Biomarkers Prev | 0.320559 |
| arteriopatÃa coronaria | 0.30952 |
| riesgo promedio | 0.330242 |
| antecedentes familiares | 0.330027 |
| Cancer Prevention Study | 0.318847 |
| Intern Med | 0.471733 |
| cohort study using | 0.309014 |
| Clin Oncol | 0.310431 |
| Services Task Force | 0.331368 |
| systematic review | 0.369209 |
| Giovannucci E | 0.31569 |
| physical activity | 0.319835 |
| Protection from | 0.309663 |
| Women’s Health Initiative | 0.324227 |
| with colorectal cancer | 0.348991 |
|
CLICK HERE |
| 2973 |
National Cancer Institute |
Video |
en |
Make Sure You Have What It Takes |
Ready to quit smoking? Make sure you have what it takes. Visit teen.smokefree.gov. |
| 02 | 0.414634 |
| ElixirMediaProd | 0.414568 |
| CDC | 0.732439 |
| QuitSmokingCom | 0.418054 |
| Sperm | 0.414461 |
| Famous People | 0.497717 |
| body | 0.415775 |
| Anti Smoking Commercial | 0.594002 |
| Disease Control | 0.79595 |
| Michael | 0.432529 |
| List | 0.414915 |
| Belhus | 0.420781 |
| Story | 0.414456 |
| Ellie | 0.41667 |
| Smokers | 0.569726 |
| Asthma Attack | 0.474832 |
| Duration | 0.939681 |
| Home Alchemy | 0.475983 |
| Hollywood | 0.417592 |
| mutation | 0.414755 |
| Smoking Advice | 0.525781 |
| Men | 0.414403 |
| Unattractive Things | 0.479984 |
| basement | 0.414589 |
|
| Smoking Timeline | 0.544895 |
| Centers | 0.483728 |
| NHS Smokefree | 0.484439 |
| Allen Carr | 0.481427 |
| Unkle Adams | 0.494687 |
| Losers Game | 0.480152 |
| air | 0.41576 |
| Aadarsh Sharma | 0.493771 |
| Videos | 0.414563 |
| Prevention | 0.483581 |
| Chicken Egg | 0.47424 |
| Great Ads | 0.480844 |
| smoking | 0.667373 |
| Smoking PSA | 0.536443 |
| views | 0.800457 |
| Terrifying | 0.418131 |
| CDC Tips | 0.549794 |
| James | 0.414466 |
| Domonic Smith | 0.486979 |
| Quit Smoking | 0.543911 |
| COPD patient | 0.483677 |
| Olly | 0.42117 |
| Planet Nibiru | 0.480348 |
| Doritos Commercial Compilation | 0.548737 |
|
CLICK HERE |